fbpx Skip to main content

THURSDAY, April 15, 2021 (HealthDay News) — Worse atopic dermatitis (AD) severity is associated with increased odds of learning disorders in pediatric patients, according to a study published online April 14 in JAMA Dermatology.

Joy Wan, M.D., from the University of Pennsylvania Perelman School of Medicine in Philadelphia, and colleagues used data from 2,074 participants (aged 2 to 17 years) in the Pediatric Eczema Elective Registry with a physician-confirmed diagnosis of AD and 10 years of follow-up.

The researchers found that 8.2 percent of participants reported a diagnosis of a learning disability. Children with a learning disability were more likely to have worse AD severity, as measured by the median total Patient-Oriented Eczema Measure (POEM) score, POEM severity category, and self-report. Participants with mild AD (odds ratio, 1.72), moderate AD (odds ratio, 2.09), and severe to very severe AD (odds ratio, 3.10) on the POEM were all significantly more likely to report a learning disability versus participants with clear or almost clear skin, after adjusting for sex, age, race/ethnicity, annual household income, age of AD onset, family history of AD, and comorbid conditions.

“The findings suggest that children with more severe AD should be screened for learning difficulties to initiate appropriate interventions that can mitigate the consequences of a learning disability,” the authors write.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

You May Also Like::  Immune Pathways May Influence Atopic Dermatitis in Blacks

“Keeping up with the indications and adverse reactions to immune checkpoint inhibitors can be a full-time job. Cutaneous side effects occur in up to 45% of patients treated with ipilimumab and 34% of patients treated with nivolumab and pembrolizumab.” https://bit.ly/3FGtxtd

.@spfnomt: This month’s #DermWorld article “Estate planning 101” is especially important for young physicians to read. The long, all-consuming years between adolescence and physicianhood can become a blur...https://bit.ly/3FxOtCv

That’s a wrap #AAD2023! 5 days of soaking up knowledge from dermatologists on topics such as hidradenitis, melasma, & dietary triggers of common dermatoses.

I LOVED the #womenshealth focused sessions on vulvar dermatoses and pregnancy medication safety.


New approach uses microbiome to treat skin disease by repairing the injured microbiome that allowed inflammation to flare up in the first place, rather than reducing the inflammation after the fact. https://bit.ly/3Jt6H9v

Load More